Dorothy Abigaba, Yadesa Tadele Mekuriya, Atukunda Esther
Department of Pharmacy, Mbarara University of Science and Technology, Mbarara, Uganda.
World Bank, ACE II, Pharmacy Biotechnology and Traditional Medicine Center, Mbarara University of Science and Technology, Mbarara, Uganda.
Cancer Manag Res. 2021 May 10;13:3739-3748. doi: 10.2147/CMAR.S307001. eCollection 2021.
Medication error is one of the most common medical errors in the practice of modern medicine. Among cancer patients receiving chemotherapy, medication errors can be potentially harmful given the narrow therapeutic index, complex dosing, and toxic nature of anti-cancer drugs.
This study aimed to determine the incidence and factors associated with medication errors among cancer patients.
The study was a prospective observational study carried out at the cancer unit of Mbarara Regional Referral Hospital, Southwestern Uganda. The study included 110 participants, both adults and children receiving chemotherapy. The study was carried out for a period of five months from January to May 2020. A checklist was used to collect patient, medication, and disease information to identify the prescription, transcription, dispensing, and administration errors.
Of the 110 participants, 52 (47.3%) experienced a total of 78 medication errors (MEs). Of these, 33 (42.31%) were prescription errors, 29 (37.18%) administration errors, 9 (11.54%) transcription errors, and 7 (8.97%) dispensing errors. In the adjusted logistic regression of factors associated with medication errors, urban residents (aOR, 4.59; 95% CI, 1.08, 19.53, = 0.039) and educated participants (at secondary level) (aOR, 10.51; 95% CI, 1.43, 77.14, = 0.021) had a significantly higher risk of experiencing medication errors. Participants treated with alkylating agents (aOR, 2.87; 95% CI, 1.07, 7.72, = 0.036) had a greater risk of experiencing medication errors when compared to other classes of chemotherapy.
The incidence of medication errors among cancer patients was high in Mbarara Regional Referral Hospital. Prescription errors were the most common type of error followed by administration errors, and dispensing errors were the least common. Residence, education level, and alkylating agent chemotherapy were significantly associated with occurrence of medication errors.
用药错误是现代医学实践中最常见的医疗错误之一。在接受化疗的癌症患者中,鉴于抗癌药物的治疗指数狭窄、给药复杂以及毒性,用药错误可能具有潜在危害。
本研究旨在确定癌症患者用药错误的发生率及相关因素。
该研究是在乌干达西南部姆巴拉拉地区转诊医院癌症科进行的一项前瞻性观察性研究。研究纳入了110名参与者,包括接受化疗的成人和儿童。研究于2020年1月至5月进行了五个月。使用一份清单收集患者、用药和疾病信息,以识别处方、转录、配药和给药错误。
在110名参与者中,52名(47.3%)共经历了78次用药错误。其中,33次(42.31%)为处方错误,29次(37.18%)为给药错误,9次(11.54%)为转录错误,7次(8.97%)为配药错误。在与用药错误相关因素的调整逻辑回归分析中,城市居民(调整后比值比,4.59;95%置信区间,1.08,19.53,P = 0.039)和受过教育(中学水平)的参与者(调整后比值比,10.51;95%置信区间,1.43,77.14,P = 0.021)发生用药错误的风险显著更高。与其他化疗类别相比,接受烷化剂治疗的参与者(调整后比值比,2.87;95%置信区间,1.07,7.72,P = 0.036)发生用药错误的风险更大。
姆巴拉拉地区转诊医院癌症患者的用药错误发生率较高。处方错误是最常见的错误类型,其次是给药错误,配药错误最不常见。居住地、教育水平和烷化剂化疗与用药错误的发生显著相关。